Effects of insulin-like growth factor I combined with growth hormone on glucocorticoid-induced whole-body protein catabolism in man

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 8, 1997, Pages 2528-2534

  Berneis, Kaspar ^a   Ninnis, Ronald ^a   Girard, Jürg ^b   Frey, Brigitte M ^c   Keller, Ulrich ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Endocrinological Practice   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOCORTICOID; GLUCOSE; GROWTH HORMONE; INSULIN; LEUCINE; METHYLPREDNISOLONE; SOMATOMEDIN C;

ADULT; ARTICLE; BIOSYNTHESIS; BODY MASS; CATABOLISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; IMPEDANCE; INSULIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN TRANSPORT; RANDOMIZED CONTROLLED TRIAL; TOTAL BODY WATER;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; DOUBLE-BLIND METHOD; FATTY ACIDS, NONESTERIFIED; GLUCAGON; HUMAN GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; KINETICS; LEUCINE; MALE; METHYLPREDNISOLONE; PLACEBOS; PROTEINS;

EID: 0030749630     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.8.2528     Document Type: Article

References (30)

1. Pagano G, Cavallo-Perin P, Cassader M, et al. 1983 An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J Clin Invest. 72:1814-1820.
2. Goldstein RE, Wassermann DH, Owen P, et al. 1993 Effects of chronic elevation in plasma cortisol on hepatic carbohydrate metabolism. Am J Physiol. 264:E119-E127.
3. Horber FF, Haymond MW. 1990 Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J Clin Invest. 86:265-272.
4. Bennet WM, Haymond MW. 1992 Growth hormone and lean tissue catabolism during long-term glucocorticoid treatment. Clin Endocrinol (Oxf). 36:161-164.
5. Oehri M, Ninnis R, Girard J, Frey FJ, Keller U. 1996 Effects of growth hormone and of IGE-I on glucocorticoid induced protein catabolism in humans. Am J Physiol. 270:E552-558.
6. Horber FF, Marsh M, Haymond MW. 1990 Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans. Diabetes. 40:141-149.
7. Laager R, Ninnis R, Keller U. 1993 Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans. J Clin Invest. 92:1903-1909.
8. Kupfer SR, Underwood LE, Baxter RC, Clemmons DR. 1993 Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. J Clin Invest. 91:391-396.
9. DeFronzo RA, Tobin JD, Andres R. 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 237:E214-E223.
10. Molina MJ, Baron AD, Edelmann SV, Brechtel G, Wallace P, Olefsky JM. 1990 Use of a variable tracer infusion method to determine glucose turnover in humans. Am J Physiol. 258:E16-E23.
11. Schwenk WF, Berg PF, Beaufrère B, Miles JM, Haymond MW. 1984 Use of T-butyldimethylsylation in the gas chromatographic-mass spectrometric analysis of physiologic compounds found in plasma using electron-impact ionization. Anal Biochem. 141:101-109.
12. Küry D, Keller U. 1991 Trimethylsilyl-O-methyloxime derivatives for the measurement of 6, 6-d2)-D-glucose enriched plasma samples using gas chromatography-mass spectroscopy. J Chromatogr. 572:302-306.
13. Bistrian BR. 1977 Nutritional assessment and therapy of protein-calorie malnutrition in the hospital. J Am Diet Assoc. 71:393.
14. Berneis K, Keller U. 1996 Metabolic actions of growth hormone: direct and indirect. Baillieres Clin Endocrinol Metab. 10:337-352.
15. Mauras N, Beaufrère B. 1995 Recombinant human insulin-like growth factor-I enhances whole body protein anabolism, and significantly diminishes the protein catabolic effects of prednisone in humans without a diabetogenic effect. J Clin Endocrinol Metab. 80:869-874.
16. Macallan D, McNurlan M, Milne E, Calder A, Garlick P, Griffin G. 1995 Whole-body protein turnover from leucine kinetics, and the response to nutrition in human immunodeficiency virus infection. Am J Clin Nutr. 61:818-826.
17. Jeevanadam M, Horowitz G, Lowry S, Brennan M. 1984 Cancer cachexia and protein metabolism. Lancet. 2:1423-1426.
18. Long C, Jeevanadam M, Kim B, Kinney J. 1977 Whole body protein synthesis and catabolism in septic man. Am J Clin Nutr. 30:1340-1344.
19. Kien C, Young V, Rohrbaugh D, Burke J. 1978 Increased rates of whole body protein synthesis and breakdown in children recovering from burns. Am Surg. 187:383-391.
20. Birkhahn R, Long C, Firkin D, Geiger J, Blakemore W. 1980 Effects of major skeletal trauma on whole body protein turnover in man measured by L-(14C) leucine. Surgery. 88:294-300.
21. Clemmons DR, Thissen JP, Maes M, Ketelslegers JM, Underwood LE. 1989 Insulin-like growth factor-I (IGF-I) infusion into hypophysectomized or protein-deprived rats induces specific IGF-binding proteins in serum. Endocrinology. 125:2967-2972.
22. Blum WF, Hall K, Ranke MB, Wilton P. 1993 Growth hormone insensitivity syndromes: a preliminary report on changes in insulin-like growth factors and their binding proteins during treatment with recombinant insulin-like growth factor I. Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes. Acta Paediatr. 391:15-19.
23. Clark RG, Mortensen D, Reifsynder D, Mohler M, Etcheverry T, Mukku V. 1993 Recombinant human insulin like growth factor-binding protein-3 (rhIGFBP-3); effects on the glycemic and growth promoting activities of rhIGF-I in the rat. Growth Regul. 3:50-52.
24. Lewitt MS, Denyer GS, Cooney GJ, Baxter RC. 1991 Insulin-like growth factor-binding protein-1 modulates blood glucose levels. Endocrinology. 129:2254-2256.
25. Tessari P, Inchiostro S, Biolo G. 1485 Hyperaminoacidaemia reduces insulin-mediated glucose disposal in healthy man. Diabetologia. 28:870-872.
26. Flakoll PJ, Wentzel LS, Rice DE, Hill JO, Abumrad NN. 1992 Short term regulation of insulin-mediated glucose utilization in four-day fasted human volunteers: role of amino acid availability. Diabetologia. 35:357-366.
27. Ferrannini E, Barrett EJ, Bevilacquq S, De Fronzo R. 1983 Effect of fatty acids on glucose production and utilization in man. J Clin Invest. 72:1737-1747.
28. Fleming RY, Rutan RL, Jahoor F, Barrow RE, Wolfe RR, Herndon DN. 1992 Effect of recombinant human growth hormone on catabolic hormones and free fatty acids following thermal injury. J Trauma. 32:698-702.
29. Guler HP, Zapf J, Froesch ER. 1987 Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med. 317:137-140.
30. Clemmons DR, Smith BA, Underwood LE. 1992 Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans. J Clin Endocrinol Metab. 75:234-238.